Pharma Reviews
Pages
Home
Pharma News
US FDA News
Pharma Jobs
Friday, March 24, 2017
US FDA News: HeartStart MRx Monitor/Defibrillator by Phillips Healthcare: Class I Recall - Electrical Issues
A delay in delivering therapy could result in serious patient injury such as permanent organ damage, brain injury, or death.
Read more:
HeartStart MRx Monitor/Defibrillator by Phillips Healthcare: Class I Recall - Electrical Issues
Newer Post
Older Post
Home
View mobile version